This is not the most recent version of the article. View current version (13 JAN 2014)

Intervention Review

Anti-IgE for chronic asthma in adults and children

  1. Samantha Walker1,*,
  2. Michele Monteil2,
  3. Kieran Phelan3,
  4. Toby J Lasserson4,
  5. E. Haydn Walters5

Editorial Group: Cochrane Airways Group

Published Online: 19 APR 2006

Assessed as up-to-date: 20 FEB 2006

DOI: 10.1002/14651858.CD003559.pub3


How to Cite

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH. Anti-IgE for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD003559. DOI: 10.1002/14651858.CD003559.pub3.

Author Information

  1. 1

    National Respiratory Training Centre, Warwick, UK

  2. 2

    Faculty of Medical Sciences, Department of ParaClinical Sciences, St Augustine, Trinidad and Tobago

  3. 3

    Cincinnati Children's Hospital Medical Center, Health Policy & Clinical Effectiveness, Cincinnati, Ohio, USA

  4. 4

    St George's, University of London, Community Health Sciences, London, UK

  5. 5

    University of Tasmania Medical School, Discipline of Medicine, Hobart, Tasmania, Australia

*Samantha Walker, National Respiratory Training Centre, The Athenaeum, 10 Church Street, Warwick, CV34 4AB, UK. s.walker@educationforhealth.org.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2006

SEARCH

This is not the most recent version of the article. View current version (13 JAN 2014)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kian Fan Chung, New treatments for severe treatment-resistant asthma: targeting the right patient, The Lancet Respiratory Medicine, 2013, 1, 8, 639

    CrossRef

  2. 2
    L. E. Ziganshina, R. R. Niyazov, A. U. Ziganshin, Registration, insurance, and medical application of biotechnological drugs in Russia, Pharmaceutical Chemistry Journal, 2013, 46, 11, 693

    CrossRef

  3. 3
    Arnaud Bourdin, Marc Humbert, Pascal Chanez, Immunologic Therapeutic Interventions in Asthma, Clinics in Chest Medicine, 2012, 33, 3, 585

    CrossRef

  4. 4
    Mina Gaga, Eleftherios Zervas, Konstantinos Samitas, Elisabeth H. Bel, Severe Asthma in Adults, Clinics in Chest Medicine, 2012, 33, 3, 571

    CrossRef

  5. 5
    Dhananjay Desai, Christopher Brightling, 2012,

    CrossRef

  6. 6
    Asma na infância: tratamento medicamentoso, Revista da Associação Médica Brasileira, 2011, 57, 4, 369

    CrossRef

  7. 7
    Asthma in childhood: drug therapy, Revista da Associação Médica Brasileira (English Edition), 2011, 57, 4, 362

    CrossRef

  8. 8
    Asthma in childhood: drug therapy, Revista da Associação Médica Brasileira, 2011, 57, 4, 362

    CrossRef

  9. 9
    Despina G. Contopoulos-Ioannidis, Maria S. Baltogianni, John P.A. Ioannidis, Comparative Effectiveness of Medical Interventions in Adults Versus Children, The Journal of Pediatrics, 2010, 157, 2, 322

    CrossRef

  10. 10
    J. D. Campbell, D. E. Spackman, S. D. Sullivan, The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective, Allergy, 2010, 65, 9
  11. 11
    Paul D. Robinson, Peter Van Asperen, Asthma in Childhood, Pediatric Clinics of North America, 2009, 56, 1, 191

    CrossRef

  12. 12
    GEMA (Guía española del manejo del asma), Archivos de Bronconeumología, 2009, 45, 2

    CrossRef

  13. 13
    J. L. Brożek, E. A. Akl, P. Alonso-Coello, D. Lang, R. Jaeschke, J. W. Williams, B. Phillips, M. Lelgemann, A. Lethaby, J. Bousquet, G. H. Guyatt, H. J. Schünemann, Grading quality of evidence and strength of recommendations in clinical practice guidelines, Allergy, 2009, 64, 5
  14. 14
    Stephen Holgate, Roland Buhl, Jean Bousquet, Nicola Smith, Zoya Panahloo, Pablo Jimenez, The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update, Respiratory Medicine, 2009, 103, 8, 1098

    CrossRef

  15. 15
    Jonathan Corren, Gail Shapiro, James Reimann, Yamo Deniz, Dennis Wong, Daniel Adelman, Alkis Togias, Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy, Journal of Allergy and Clinical Immunology, 2008, 121, 2, 506

    CrossRef

  16. 16
    Bradley E. Chipps, Asthma in Infants and Children, Clinical Cornerstone, 2008, 8, 4, 44

    CrossRef

  17. 17
    J.A. Castillo Laita, J. De Benito Fernández, A. Escribano Montaner, M. Fernández Benítez, S. García de la Rubia, J. Garde Garde, L. García-Marcos, C. González Díaz, M. Ibero Iborra, M. Navarro Merino, C. Pardos Martínez, J. Pellegrini Belinchon, J. Sánchez Jiménez, J. Sanz Ortega, J.R. Villa Asensi, Consensus Statement on the Management of Paediatric Asthma. Update 2007, Allergologia et Immunopathologia, 2008, 36, 1, 31

    CrossRef

  18. 18
    L. B. Bacharier, A. Boner, K.-H. Carlsen, P. A. Eigenmann, T. Frischer, M. Götz, P. J. Helms, J. Hunt, A. Liu, N. Papadopoulos, T. Platts-Mills, P. Pohunek, F. E. R. Simons, E. Valovirta, U. Wahn, J. Wildhaber, Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report, Allergy, 2008, 63, 1
  19. 19
    R. Niven, K.F. Chung, Z. Panahloo, M. Blogg, G. Ayre, Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: An open-label study, Respiratory Medicine, 2008, 102, 10, 1371

    CrossRef

  20. 20
    Gary P Anderson, Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease, The Lancet, 2008, 372, 9643, 1107

    CrossRef

  21. 21
    Riccardo Polosa, Jaymin Morjaria, Immunomodulatory and biologic therapies for severe refractory asthma, Respiratory Medicine, 2008, 102, 11, 1499

    CrossRef

  22. 22
    C. Rolinck-Werninghaus, T. Keil, M. Kopp, S. Zielen, U. Schauer, A. Von Berg, U. Wahn, E. Hamelmann, Specific IgE serum concentration is associated with symptom severity in children with seasonal allergic rhinitis, Allergy, 2008, 63, 10
  23. 23
    Susana Marinho, Adnan Custovic, Clinical Immunology, 2008,

    CrossRef

  24. 24
    Linda Cox, James T. Li, Harold Nelson, Richard Lockey, Allergen immunotherapy: A practice parameter second update, Journal of Allergy and Clinical Immunology, 2007, 120, 3, S25

    CrossRef

  25. 25
    Godfrey J.A. Walker, Damian G. Walker, Congenital syphilis: A continuing but neglected problem, Seminars in Fetal and Neonatal Medicine, 2007, 12, 3, 198

    CrossRef

  26. 26
    Ann C. Wu, A. David Paltiel, Karen M. Kuntz, Scott T. Weiss, Anne L. Fuhlbrigge, Cost-effectiveness of omalizumab in adults with severe asthma: Results from the Asthma Policy Model, Journal of Allergy and Clinical Immunology, 2007, 120, 5, 1146

    CrossRef

  27. 27
    R. Abou Taam, J. de Blic, M. Le Bourgeois, C. Karila, P. Scheinmann, Nouveautés en pneumologie et en allergologie pédiatriques, Revue Française d'Allergologie et d'Immunologie Clinique, 2007, 47, 2, 84

    CrossRef

  28. 28
    Jerry A. Krishnan, Michael Gould, Omalizumab for severe allergic asthma: Dollars and sense, Journal of Allergy and Clinical Immunology, 2007, 120, 5, 1015

    CrossRef

  29. 29
    Paul M O'Byrne, Krishnan Parameswaran, Pharmacological management of mild or moderate persistent asthma, The Lancet, 2006, 368, 9537, 794

    CrossRef

  30. 30
    Kana R Jat, Dinesh K Walia, Anju Khairwa, Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis, The Cochrane Library,
  31. 31
    Kana R Jat, Dinesh K Walia, Anju Khairwa, Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis, The Cochrane Library,
  32. 32
    Ann Dewey, Anna Bara, Toby J Lasserson, E. Haydn Walters, Chloroquine as a steroid sparing agent for asthma, The Cochrane Library,
  33. 33
    Ashley M Croft, Peter Bager, Sushil Kumar, Pat Manning, Helminths for asthma, The Cochrane Library,
  34. 34
    Rebecca Normansell, Samantha Walker, Stephen J Milan, E. Haydn Walters, Parameswaran Nair, Omalizumab for asthma in adults and children, The Cochrane Library,